-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Im5UsBqNa0Qut9YtCr24doRXbRI4NxQ/POJkD7au9mqgocFOznrN8K8K7hwab7GO uTuIAMmYDeoGdjmMC/S09g== 0001104659-08-009083.txt : 20080211 0001104659-08-009083.hdr.sgml : 20080211 20080211185806 ACCESSION NUMBER: 0001104659-08-009083 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080207 FILED AS OF DATE: 20080211 DATE AS OF CHANGE: 20080211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: 125 CAMBRIDGEPARK DRIVE, 6TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02140 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEWIS JEROME M CENTRAL INDEX KEY: 0001225855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14732 FILM NUMBER: 08595261 BUSINESS ADDRESS: BUSINESS PHONE: 6174972070 MAIL ADDRESS: STREET 1: C/O ADVANCED MAGNETICS INC STREET 2: 61 MOONEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02138 4 1 a4.xml 4 X0202 4 2008-02-07 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001225855 LEWIS JEROME M C/O AMAG PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 0 1 0 0 VP of Scientific Opertaions Common Stock 2008-02-07 4 S 0 1750 52.99 D 1042 D Common Stock 2008-02-07 4 M 0 1000 0 A 2042 D Common Stock 2008-02-07 4 M 0 625 8.42 A 2667 D Common Stock 2008-02-07 4 M 0 750 10.87 A 3417 D Common Stock 2008-02-07 4 M 0 750 14.24 A 4167 D Common Stock 2008-02-07 4 M 0 1000 16.80 A 5167 D Common Stock 2008-02-07 4 M 0 1000 9.11 A 6167 D Common Stock 2008-02-07 4 M 0 6778 19.98 A 12945 D Common Stock 2008-02-07 4 M 0 5222 19.98 A 18167 D Employee Stock Option (Right to Buy) 8.42 2008-02-07 4 M 0 625 0 D 2013-08-12 Common Stock 625 0 D Employee Stock Option (Right to Buy) 10.87 2008-02-07 4 M 0 750 0 D 2014-02-03 Common Stock 750 0 D Employee Stock Option (Right to Buy) 14.24 2008-02-07 4 M 0 750 0 D 2014-08-03 Common Stock 750 750 D Employee Stock Option (Right to Buy) 16.80 2008-02-07 4 M 0 1000 0 D 2015-02-01 Common Stock 1000 1000 D Employee Stock Option (Right to Buy) 9.11 2008-02-07 4 M 0 1000 0 D 2015-11-15 Common Stock 1000 2000 D Employee Stock Option (Right to Buy) 19.98 2008-02-07 4 M 0 6778 0 D 2016-02-07 Common Stock 6778 0 D Employee Stock Option (Right to Buy) 19.98 2008-02-07 4 M 0 5222 0 D 2016-02-07 Common Stock 5222 0 D Restricted Stock Unit 2008-02-07 4 M 0 1000 0 D Common Stock 1000 2000 D The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person. The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share ranged from $52.76 to $53.30. Mr. Lewis owns such shares jointly with his spouse. Grant of stock option pursuant to the AMAG Pharmaceuticals, Inc. (the "Company") Amended and Restated 2000 Stock Plan (the "2000 Plan"). This option was exercisable in four equal annual installments. The final installment became exercisable on August 12, 2007. Grant of stock option pursuant to the Company's 2000 Plan. This option was exercisable in four equal annual installments. The final installment became exercisable on February 3, 2008. Grant of stock option pursuant to the Company's 2000 Plan. This option is exercisable in four equal annual installments. The first three installments became exercisable on August 3, 2005, August 3, 2006, and August 3, 2007. The final installment will become exercisable on August 3, 2008. Grant of stock option pursuant to the Company's 2000 Plan. This option is exercisable in four equal annual installments. The first three installments became exercisable on February 1, 2006, February 1, 2007, and February 1, 2008. The final installment will become exercisable on February 1, 2009. Grant of stock option pursuant to the Company's 2000 Plan. This option is exercisable in four equal annual installments. The first two installments became exercisable on November 15, 2006 and November 15, 2007. The remaining installments will become exercisable on November 15, 2008 and November 15, 2009. Grant of stock option pursuant to the Company's 2000 Plan. This option was exercisable in four semi-annual installments. The final installment became exercisable on February 7, 2008. Grant of incentive stock option pursuant to the Company's 2000 Plan. This option was exercisable in four semi-annual installments. The final installment became exercisable on February 7, 2008. Grant of restricted stock units pursuant to the Company's 2000 Plan. This restricted stock unit grant vests in four equal annual installments. The first two installments vested on February 7, 2007 February 7, 2008. The final installments vest on February 7, 2009 and February 7, 2010. Restricted stock unit grants do not have an exercise price. Upon each vesting date, the amount of underlying shares of common stock corresponding to such vested installment are issued to the reporting person. /s/ Joseph L. Farmer, attorney-in-fact 2008-02-11 -----END PRIVACY-ENHANCED MESSAGE-----